Follow
Sally Kelliny
Sally Kelliny
Lecturer Assistant, Faculty of Pharmacy, Assiut University
Verified email at aun.edu.eg
Title
Cited by
Cited by
Year
Long term high fat diet induces metabolic disorders and aggravates behavioral disorders and cognitive deficits in MAPT P301L transgenic mice
J Xiong, I Deng, S Kelliny, L Lin, L Bobrovskaya, XF Zhou
Metabolic Brain Disease 37 (6), 1941-1957, 2022
112022
A new approach to model sporadic Alzheimer’s disease by intracerebroventricular streptozotocin injection in APP/PS1 mice
S Kelliny, L Lin, I Deng, J Xiong, F Zhou, M Al-Hawwas, L Bobrovskaya, ...
Molecular Neurobiology 58, 3692-3711, 2021
92021
Peripheral ProBDNF delivered by an AAV vector to the muscle triggers depression-like behaviours in mice
LY Lin, S Kelliny, LC Liu, M Al-Hawwas, XF Zhou, L Bobrovskaya
Neurotoxicity Research 38, 626-639, 2020
72020
Preclinical study of the pharmacokinetics of p75ECD-Fc, a novel human recombinant protein for treatment of Alzheimer’s disease, in Sprague Dawley rats
S Kelliny, HY Lam, A Parikh, YJ Wang, L Bobrovskaya, R Upton, XF Zhou
Current Drug Metabolism 21 (3), 235-244, 2020
72020
Preclinical validation of a novel oral Edaravone formulation for treatment of frontotemporal dementia
S Kelliny, J Xiong, L Bobrovskaya, XF Zhou
Neurotoxicity Research 39, 1689-1707, 2021
22021
Pharmacokinetic Modelling of Human Recombinant Protein, p75ECD-Fc: A Novel Therapeutic Approach for Treatment of Alzheimer’s Disease, in Serum and Tissue of Sprague Dawley Rats
S Kelliny, L Bobrovskaya, XF Zhou, R Upton
European Journal of Drug Metabolism and Pharmacokinetics 46, 235-248, 2021
12021
Sporadic Alzheimer’s disease animal model using streptozotocin and APP/PS1 mice
S Kelliny, I Deng, XF Zhou, L Bobrovskaya
Handbook of Animal Models in Neurological Disorders, 17-30, 2023
2023
A Novel Oral Edaravone Formulation Partially Alleviates Tau Pathology and Motor Deficits in an Animal Model of Frontotemporal Dementia
S Kelliny, J Xiong, L Bobrovskaya, XF Zhou
2021
The system can't perform the operation now. Try again later.
Articles 1–8